LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article: Incidence, pattern and severity of abnormal liver blood tests among hospitalised patients with SARS-COV2 (COVID-19) in South Wales.

    Yeoman, Andrew / Maggs, Daniel Raun / Gardezi, Syed A A / Haboubi, Hasan Nadim / Yahya, Muhammad Imran / Yousuf, Fidan / Czajkowski, Marek Alexander

    Frontline gastroenterology

    2020  Volume 12, Issue 2, Page(s) 89–94

    Abstract: ... severity of liver blood test abnormalities in hospitalised patients with confirmed COVID-19 ... blood tests available for analysis. Ninety-seven patients (31%) had one or more abnormal liver blood tests and ... hospital discharge and mortality were recorded.: Results: 318 hospitalised COVID-19 positive had liver ...

    Abstract Introduction: SARS-CoV-2 (COVID-19) is a novel coronavirus that emerged in Wuhan, China in late 2019 and since become a global pandemic. As such, its clinical behaviour is a subject of much interest. Initial reports suggested a significant proportion of patients have abnormal liver blood tests. Gwent has experienced one of the highest incidences of COVID-19 infection in the UK, which itself has among the highest COVID-19 impacts worldwide.
    Method: We set out to report the incidence, clinical pattern and severity of liver blood test abnormalities in hospitalised patients with confirmed COVID-19 in our institution over a 3-week period. Data on clinical outcomes such as admission to intensive therapy unit (ITU), hospital discharge and mortality were recorded.
    Results: 318 hospitalised COVID-19 positive had liver blood tests available for analysis. Ninety-seven patients (31%) had one or more abnormal liver blood tests and were abnormal admission in 64%. Liver tests were predominantly cholestatic (72%) in contrast to other studies to date. Male gender and abnormal liver blood tests were associated with ITU admission.
    Conclusions: Almost one-third of admissions with COVID-19 have abnormal LBTs which are typically mild and are associated with male gender. Importantly, we have identified that cholestatic patterns dominate but were not clearly associated with ITU admission or death.
    Language English
    Publishing date 2020-08-21
    Publishing country England
    Document type Journal Article
    ZDB-ID 2521857-8
    ISSN 2041-4137
    ISSN 2041-4137
    DOI 10.1136/flgastro-2020-101532
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Incidence, pattern and severity of abnormal liver blood tests among hospitalised patients with SARS-COV2 (COVID-19) in South Wales

    Yeoman, A. / Maggs, D. R. / Gardezi, S. A. A. / Haboubi, H. N. / Yahya, M. I. / Yousuf, F. / Czajkowski, M. A.

    Frontline Gastroenterology

    Abstract: ... discharge and mortality were recorded Results: 318 hospitalised COVID-19 positive had liver blood tests ... of liver blood test abnormalities in hospitalised patients with confirmed COVID-19 in our institution over ... available for analysis Ninety-seven patients (31%) had one or more abnormal liver blood tests and were ...

    Abstract Introduction: SARS-CoV-2 (COVID-19) is a novel coronavirus that emerged in Wuhan, China in late 2019 and since become a global pandemic As such, its clinical behaviour is a subject of much interest Initial reports suggested a significant proportion of patients have abnormal liver blood tests Gwent has experienced one of the highest incidences of COVID-19 infection in the UK, which itself has among the highest COVID-19 impacts worldwide Method: We set out to report the incidence, clinical pattern and severity of liver blood test abnormalities in hospitalised patients with confirmed COVID-19 in our institution over a 3-week period Data on clinical outcomes such as admission to intensive therapy unit (ITU), hospital discharge and mortality were recorded Results: 318 hospitalised COVID-19 positive had liver blood tests available for analysis Ninety-seven patients (31%) had one or more abnormal liver blood tests and were abnormal admission in 64% Liver tests were predominantly cholestatic (72%) in contrast to other studies to date Male gender and abnormal liver blood tests were associated with ITU admission Conclusions: Almost one-third of admissions with COVID-19 have abnormal LBTs which are typically mild and are associated with male gender Importantly, we have identified that cholestatic patterns dominate but were not clearly associated with ITU admission or death
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #767979
    Database COVID19

    Kategorien

  3. Article ; Online: Incidence, pattern and severity of abnormal liver blood tests among hospitalised patients with SARS-COV2 (COVID-19) in South Wales

    Yeoman, Andrew / Maggs, Daniel Raun / Gardezi, Syed A A / Haboubi, Hasan Nadim / Yahya, Muhammad Imran / Yousuf, Fidan / Czajkowski, Marek Alexander

    Frontline Gastroenterology

    2020  , Page(s) flgastro–2020–101532

    Abstract: ... discharge and mortality were recorded. Results 318 hospitalised COVID-19 positive had liver blood tests ... of liver blood test abnormalities in hospitalised patients with confirmed COVID-19 in our institution over ... available for analysis. Ninety-seven patients (31%) had one or more abnormal liver blood tests and were ...

    Abstract Introduction SARS-CoV-2 (COVID-19) is a novel coronavirus that emerged in Wuhan, China in late 2019 and since become a global pandemic. As such, its clinical behaviour is a subject of much interest. Initial reports suggested a significant proportion of patients have abnormal liver blood tests. Gwent has experienced one of the highest incidences of COVID-19 infection in the UK, which itself has among the highest COVID-19 impacts worldwide. Method We set out to report the incidence, clinical pattern and severity of liver blood test abnormalities in hospitalised patients with confirmed COVID-19 in our institution over a 3-week period. Data on clinical outcomes such as admission to intensive therapy unit (ITU), hospital discharge and mortality were recorded. Results 318 hospitalised COVID-19 positive had liver blood tests available for analysis. Ninety-seven patients (31%) had one or more abnormal liver blood tests and were abnormal admission in 64%. Liver tests were predominantly cholestatic (72%) in contrast to other studies to date. Male gender and abnormal liver blood tests were associated with ITU admission. Conclusions Almost one-third of admissions with COVID-19 have abnormal LBTs which are typically mild and are associated with male gender. Importantly, we have identified that cholestatic patterns dominate but were not clearly associated with ITU admission or death.
    Keywords covid19
    Language English
    Publisher BMJ
    Publishing country uk
    Document type Article ; Online
    ZDB-ID 2521857-8
    ISSN 2041-4137
    ISSN 2041-4137
    DOI 10.1136/flgastro-2020-101532
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top